Trial intelligence / Profile preview

Decitabine + Carboplatin in Platinum-Resistant Ovarian Cancer

NCT00477386Phase 2Completed

Sponsor
Indiana University
Start
Jul 2007
Primary completion
May 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of decitabine in ovarian cancer, sponsored by Indiana University. Started Jul 2007; status: completed.

02

Drugs

decitabine
03

Conditions

ovarian cancer

Beyond the preview

Go deeper on NCT00477386.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00477386.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call